Clinical trial
Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications…
NCT00375518 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00375518 |
|---|---|
| Title | Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery |
| Official title | Double-Blind Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Thoracic Surgery |
| Intervention type | Drug |
| Interventions | Atorvastatin, Placebo |
| Enrollment | 162 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2014 |
| Completion | May 1, 2014 |
| First posted | Sep 13, 2006 |
| Last update posted | Jan 6, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: